These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28584105)

  • 1. Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake.
    Chicca A; Nicolussi S; Bartholomäus R; Blunder M; Aparisi Rey A; Petrucci V; Reynoso-Moreno IDC; Viveros-Paredes JM; Dalghi Gens M; Lutz B; Schiöth HB; Soeberdt M; Abels C; Charles RP; Altmann KH; Gertsch J
    Proc Natl Acad Sci U S A; 2017 Jun; 114(25):E5006-E5015. PubMed ID: 28584105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
    Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
    Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for bidirectional endocannabinoid transport across cell membranes.
    Chicca A; Marazzi J; Nicolussi S; Gertsch J
    J Biol Chem; 2012 Oct; 287(41):34660-82. PubMed ID: 22879589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors.
    Chicca A; Marazzi J; Gertsch J
    Br J Pharmacol; 2012 Dec; 167(8):1596-608. PubMed ID: 22646533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid biosynthesis and inactivation, from simple to complex.
    Muccioli GG
    Drug Discov Today; 2010 Jun; 15(11-12):474-83. PubMed ID: 20304091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation.
    Ortar G; Cascio MG; Moriello AS; Camalli M; Morera E; Nalli M; Di Marzo V
    Eur J Med Chem; 2008 Jan; 43(1):62-72. PubMed ID: 17452063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
    Pertwee RG
    Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
    Giuffrida A; Beltramo M; Piomelli D
    J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.
    Iannotti FA; Di Marzo V; Petrosino S
    Prog Lipid Res; 2016 Apr; 62():107-28. PubMed ID: 26965148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.
    Turcotte C; Chouinard F; Lefebvre JS; Flamand N
    J Leukoc Biol; 2015 Jun; 97(6):1049-70. PubMed ID: 25877930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of endocannabinoids across the plasma membrane and within the cell.
    Fowler CJ
    FEBS J; 2013 May; 280(9):1895-904. PubMed ID: 23441874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
    Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses.
    Busquets-Garcia A; Puighermanal E; Pastor A; de la Torre R; Maldonado R; Ozaita A
    Biol Psychiatry; 2011 Sep; 70(5):479-86. PubMed ID: 21684528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs.
    Batista LA; Gobira PH; Viana TG; Aguiar DC; Moreira FA
    Behav Pharmacol; 2014 Sep; 25(5-6):425-33. PubMed ID: 25083569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study.
    Wiskerke J; Irimia C; Cravatt BF; De Vries TJ; Schoffelmeer AN; Pattij T; Parsons LH
    ACS Chem Neurosci; 2012 May; 3(5):407-17. PubMed ID: 22860210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake?
    Fowler CJ; Ghafouri N
    Pharmacol Res; 2008 Jul; 58(1):72-6. PubMed ID: 18675915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
    Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
    Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
    Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.